Establishment and Characterization of Four Novel Thyroid Cancer Cell Lines and PDX Models Expressing the RET/PTC1 Rearrangement, BRAFV600E, or RASQ61R as Drivers-Reference-Cited by-同舟云学术

Establishment and Characterization of Four Novel Thyroid Cancer Cell Lines and PDX Models Expressing the RET/PTC1 Rearrangement, BRAFV600E, or RASQ61R as Drivers

Published:2019-02-07 Issue:5 Volume:17 Page:1036-1048
ISSN:1541-7786
Container-title:Molecular Cancer Research
language:en
Short-container-title:Mol Cancer Res

Author:

Schweppe Rebecca E.^ORCID,Pozdeyev Nikita,Pike Laura A.,Korch Christopher,Zhou Qiong,Sams Sharon B.,Sharma Vibha,Pugazhenthi Umarani,Raeburn Christopher,Albuja-Cruz Maria B.,Reigan Philip,LaBarbera Daniel V.,Landa Iñigo^ORCID,Knauf Jeffrey A.^ORCID,Fagin James A.,Haugen Bryan R.

Funder

NCI

American Cancer Society

NIH

NIHNCINCI

Linn Family Fund

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology,Molecular Biology

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular genetic markers of highly differentiated thyroid cancer (literature review and personal observations);The Ukrainian Journal of Clinical Surgery;2024-04-20

2. Mcl-1 mediates intrinsic resistance to RAF inhibitors in mutant BRAF papillary thyroid carcinoma;Cell Death Discovery;2024-04-15

3. The effects of Aurora Kinase inhibition on thyroid cancer growth and sensitivity to MAPK-directed therapies;Cancer Biology & Therapy;2024-03-23

4. Advances in targeted therapy and biomarker research in thyroid cancer;Frontiers in Endocrinology;2024-03-04

5. Fibronectin Contributes to a BRAF Inhibitor–driven Invasive Phenotype in Thyroid Cancer through EGR1, Which Can Be Blocked by Inhibition of ERK1/2;Molecular Cancer Research;2023-05-23